Heron Therapeutics Inc. (HRTX) at a glance

Heron Therapeutics Inc. (HRTX) is a micro-cap Healthcare company. It trades at $0.47, with a -20.5% profit margin and revenue decline of 10.8%. It does not pay a dividend. Vestovix scores it 27/100 overall. Its strongest dimension is Income (40/100) and its weakest is Momentum (16/100). It carries above-market volatility, so expect larger swings.

Price

$0.47

Market cap

$75.7M

P/E ratio

n/a

Dividend yield

None

Beta

1.57

52-week range

$0.38 to $1.99